Exercise training in patients with pulmonary arterial hypertension: a case report.
OBJECTIVE
To describe the benefits of a feasible, outpatient exercise training program on exercise tolerance and health-related quality of life (HRQL) in individuals with pulmonary arterial hypertension (PAH).


METHODS
Case report on two subjects recruited from a tertiary care pulmonary hypertension clinic. Subject 1 was a 50-year-old male with idiopathic PAH. Subject 2 was a 54-year-old female with a 20+ year history of scleroderma and 6-year history of PAH. Both subjects underwent exercise training 3 times per week for 6 weeks using a cycle ergometer at workloads progressing from 50% to 80% of peak workload. Outcomes were assessed using cardiopulmonary exercise testing, six-minute walk test (6MWT), and HRQL using the Chronic Respiratory Disease Questionnaire (CRQ) and the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR).


RESULTS
Both subjects made substantial improvements in oxygen consumption and workload at anaerobic threshold (improvements of 3.8 and 4.2 mL.kg(-1).min,(-1) 26 and 18 W, respectively) and 6MWT distance (from 496 to 586m and 416 to 517m, respectively). Only Subject 1 made substantial improvements in peak oxygen consumption (from 16.0 to 18.3 mL.kg(-1).min(-1)and from 15.0 to 15.6 mL.kg(-1).min,(-1) respectively) and peak work rate (from 112 to 130W and 66 to 69W, respectively). Both subjects demonstrated improved HRQL. No adverse events were noted.


CONCLUSIONS
A short and practical exercise training program can improve measures of workload, aerobic capacity, and HRQL in individuals with PAH with no adverse effects shown in these two case studies.
Shoemaker
Michael J
MJ
Grand Valley State University, Physical Therapy Program, Grand Rapids, MI.
Wilt
Jeffrey L
JL
Dasgupta
Rajkumar
R
Oudiz
Ronald J
RJ
Heart. 1998 Oct;80(4):377-82
9875117
Chest. 1998 Apr;113(4 Suppl):263S-268S
9552016
Am J Respir Crit Care Med. 2005 May 1;171(9):972-7
15665324
Semin Respir Crit Care Med. 2005 Aug;26(4):379-84
16121314
Am J Pathol. 1999 Aug;155(2):411-9
10433934
Ann Intern Med. 1987 Aug;107(2):216-23
3605900
Am J Respir Crit Care Med. 2006 Jun 15;173(12):1390-413
16760357
Circulation. 1999 Mar 9;99(9):1173-82
10069785
Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003793
17054186
Qual Life Res. 2006 Feb;15(1):103-15
16411035
J Am Coll Cardiol. 2003 Mar 19;41(6):1028-35
12651053
Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1666-82
10228143
Circulation. 2006 Oct 3;114(14):1482-9
16982941
Chest. 2005 May;127(5):1637-46
15888840
Am J Respir Crit Care Med. 2005 Jul 1;172(1):19-38
15778487
Can Med Assoc J. 1985 Apr 15;132(8):919-23
3978515
N Engl J Med. 1996 Feb 1;334(5):296-301
8532025
N Engl J Med. 2004 Sep 30;351(14):1425-36
15459304
Am J Respir Crit Care Med. 1997 Apr;155(4):1278-82
9105067
Circulation. 2003 Mar 4;107(8):1210-25
12615804
MMWR Surveill Summ. 2005 Nov 11;54(5):1-28
16280974
Chest. 2004 Nov;126(5):1452-9
15539712
Control Clin Trials. 1989 Dec;10(4):407-15
2691207
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
12091180
Curr Opin Cardiol. 2006 Jul;21(4):385-92
16755209
Circulation. 1988 Sep;78(3):506-15
3409495
Cochrane Database Syst Rev. 2004;(3):CD003331
15266480
Chest. 2004 Jul;126(1 Suppl):7S-10S
15249491
Thorax. 1984 Nov;39(11):818-22
6505988
Am J Respir Crit Care Med. 2003 Nov 1;168(9):1034-42
12869359
Circulation. 2001 Jul 24;104(4):429-35
11468205
Clin Sci (Lond). 2008 Jan;114(2):165-71
17764445
Cochrane Database Syst Rev. 2005 Apr 18;(2):CD002994
15846646
Thorax. 1987 Oct;42(10):773-8
3321537
J Am Coll Cardiol. 1997 Aug;30(2):343-9
9247503
BMJ. 2003 Apr 19;326(7394):835-6
12702599
J Heart Lung Transplant. 2008 Jan;27(1):124-30
18187098
J Am Coll Cardiol. 2004 Jun 16;43(12 Suppl S):48S-55S
15194178
J Cardiol. 2005 Nov;46(5):183-93
16320975
Chest. 2004 Sep;126(3):816-24
15364761
J Heart Lung Transplant. 2004 Jan;23(1):88-95
14734132